Details

Autor(en) / Beteiligte

• Cerrato, Clara
• Pandolfo, Savio Domenico
• Autorino, Riccardo
• Panunzio, Andrea
• Tafuri, Alessandro
• Porcaro, Antonio Benito
• Veccia, Alessandro
• De Marco, Vincenzo
• Cerruto, Maria Angela
• Antonelli, Alessandro
• Derweesh, Ithaar H.
• Maresma, Maria Carmen Mir

Titel

Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome

Ist Teil von

• World journal of urology, 2023-07, Vol.41 (7), p.1741-1749

Ort / Verlag

Berlin/Heidelberg: Springer Berlin Heidelberg

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• Purpose Lynch syndrome (LS) is an autosomal dominant genetic syndrome resulting in a wide spectrum of malignancies caused by germline mutations in mismatch repair genes (MMR). Gene mutations have different effects and penetrance between the two genders. The aim of this review is to offer a gender-specific evidence-based clinical guide on diagnosis, screening, surveillance, and counselling of UTUC patients with LS. Methods Using MEDLINE, a non-systematic review was performed including articles between 2004 and 2022. English language original articles, reviews, and editorials were selected based on their clinical relevance. Results Upper tract urothelial carcinoma (UTUC) is the third most common malignancy in Lynch syndrome. Up to 21% of new UTUC cases may have unrecognized LS as the underlying cause. LS-UTUC does not have a clear gender prevalence, even if it seems to slightly prefer the male gender. The MSH6 variant is significantly associated with female gender ( p  < 0.001) and with gynecological malignancies. Female MSH2 and MLH1 carriers have higher rates for endometrial and ovarian cancer with respect to the general population, while male MSH2 and MLH1 carriers have, respectively, higher rate of prostate cancer and upper GI tract, or biliary or pancreatic cancers. Conflicting evidence remains on the association of testicular cancer with LS. Conclusion LS is a polyhedric disease, having a great impact on patients and their families that requires a multidisciplinary approach. UTUC patients should be systematically screened for LS, and urologists have to be aware that the same MMR mutation may lead to different malignancies according to the patient’s gender.